• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vet Res . E627V mutation in PB2 protein promotes the mammalian adaptation of novel H10N3 avian influenza virus

tetano

Editor, Senior Moderator
Vet Res


. 2025 Jun 8;56(1):111.
doi: 10.1186/s13567-025-01534-8. E627V mutation in PB2 protein promotes the mammalian adaptation of novel H10N3 avian influenza virus

Meishan Song[SUP] #[/SUP][SUP] 1 [/SUP], Jianyu Liang[SUP] #[/SUP][SUP] 1 [/SUP], Sige Wang[SUP] #[/SUP][SUP] 1 [/SUP], Ruyi Gao[SUP] 1 2 3 [/SUP], Xiaolong Lu[SUP] 1 2 3 [/SUP], Wenhao Yang[SUP] 1 2 3 [/SUP], Yu Chen[SUP] 1 2 3 [/SUP], Jingxia Ma[SUP] 4 [/SUP], Min Gu[SUP] 1 2 3 [/SUP], Jiao Hu[SUP] 1 2 3 [/SUP], Xiaowen Liu[SUP] 1 2 3 [/SUP], Shunlin Hu[SUP] 1 2 3 [/SUP], Xiaoquan Wang[SUP] 5 6 7 8 [/SUP], Kaituo Liu[SUP] 9 10 11 12 [/SUP], Xiufan Liu[SUP] 13 1 2 3 [/SUP]



Affiliations
Abstract

Since 2021, the novel H10N3 has caused four cases of human infection in China, the most recent of which occurred in December 2024, posing a potential threat to public health. Our previous studies indicated that several avian H10N3 strains are highly pathogenic in mice and can be transmitted between mammals via respiratory droplets without prior adaptation. By analyzing the genome sequence, we found that these H10N3 viruses carry the PB2-E627V mutation, which is becoming increasingly common in several subtypes of avian influenza viruses (AIV); however, its mechanism in mammalian adaptation remains unclear. Using a reverse genetics system, we investigated the role of PB2-E627V in the adaptation of H10N3 to mammals and poultry. Our findings demonstrate that the PB2-E627V mutation is critical for the high pathogenicity of novel H10N3 in mice and its ability to be transmitted through the air among mammals. Additionally, we found that the role of PB2-627 V in promoting AIV adaptation to mammals is comparable to that of PB2-627 K. More importantly, PB2-627 V appears to be equally suited to long-term persistence in poultry. Therefore, using PB2-627 V as a novel molecular marker to assess the epidemic potential of AIV is of great significance for preventing possible influenza pandemics in the future.

Keywords: Avian influenza virus; PB2-E627V/K; mammal adaption; novel H10N3.

 
Back
Top Bottom